| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $39,687,953 ) (Continued on the next page) |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI196092 | Decoding the role of Aire-expressing Thetis cells in peripheral self-tolerance | 000 | 1 | NIH | 2/3/2026 | $616,042 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MH135403 | Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals | 000 | 3 | NIH | 12/2/2025 | $706,519 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | U01AI187049 | Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE | 000 | 2 | NIH | 1/7/2026 | $616,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI034206 | Self-Peptides Bound to MHC Class II in T Cell Selection | 000 | 32 | NIH | 11/26/2025 | $698,720 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI182389 | Small-Molecule Penetration and Efflux in Gram-Negative Bacteria | 000 | 3 | NIH | 1/16/2026 | $1,203,141 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI130345 | Development of the resident macrophage lineage in mouse and human | 000 | 9 | NIH | 1/9/2026 | $698,261 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA293974 | Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) | 000 | 2 | NIH | 3/3/2026 | $681,611 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD019804 | RSMI HEALS | 000 | 3 | NIH | 3/4/2026 | $738,562 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA300788 | Inflammatory Signaling in the Leptomeninges | 000 | 2 | NIH | 3/3/2026 | $730,398 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG087529 | Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease | 000 | 2 | NIH | 12/18/2025 | $783,983 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG080684 | Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | 000 | 4 | NIH | 12/3/2025 | $718,002 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA299865 | Emergence of tumor regenerative states during neoadjuvant therapy in locally advanced rectal cancer: selection or adaptation? | 000 | 1 | NIH | 3/17/2026 | $730,398 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM156454 | Decoding the Ubiquitin and Autophagy Signaling Networks | 000 | 2 | NIH | 2/19/2026 | $440,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA266185 | Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem Cells | 000 | 5 | NIH | 2/11/2026 | $364,399 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA270116 | Targeting plasticity in lung cancer | 000 | 4 | NIH | 2/11/2026 | $550,161 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA271186 | Probabilistic Multiscale Modeling of the Tumor Microenvironment | 000 | 4 | NIH | 12/17/2025 | $622,736 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA244911 | Targeting stem-like cells and their niche in pancreatic cancer | 000 | 7 | NIH | 2/18/2026 | $441,764 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI100874 | The natural killer cell response against mouse cytomegalovirus infection | 000 | 14 | NIH | 12/8/2025 | $630,290 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 000 | 7 | NIH | 12/11/2025 | $411,861 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA266068 | Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism | 000 | 4 | NIH | 12/17/2025 | $518,111 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD016908 | Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity) | 001 | 5 | NIH | 2/17/2026 | $71,885 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA295658 | Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining | 000 | 2 | NIH | 12/11/2025 | $606,609 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R37CA261183 | Immune control and genomic instability at micronuclei | 000 | 5 | NIH | 12/23/2025 | $424,822 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99AI196248 | Investigating the developmental and transcriptional bases for distinct functions of IL-10+ and IL-10− Treg cells | 000 | 1 | NIH | 3/27/2026 | $167,951 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K08CA279922 | Defining the role of GNAS in gastrointestinal metastasis | 000 | 4 | NIH | 3/27/2026 | $268,826 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99CA297030 | Metabolically Reprogramming Hepatic Macrophages to Conquer Immune Desert Tumors | 000 | 2 | NIH | 2/27/2026 | $145,336 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA288880 | Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal Cancer | 000 | 3 | NIH | 3/9/2026 | $402,600 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R00HG012973 | Molecular recording to understand the determinants of cell fate transitions in early development | 000 | 4 | NIH | 3/9/2026 | $249,000 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA274249 | Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma | 000 | 4 | NIH | 2/26/2026 | $694,645 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K99CA297013 | Developing and Validating Prognostic Models for Black women with Endometrial Cancer following Hysterectomy | 000 | 2 | NIH | 2/27/2026 | $132,825 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM152017 | Teaching free energy calculations to learn | 000 | 3 | NIH | 2/26/2026 | $538,560 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | F32CA298730 | Investigating the Role of Mutagenic DNA Repair during the Persistence of Cancer Cells | 000 | 2 | NIH | 3/27/2026 | $83,830 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AT013147 | Isoquercetin as a PDI inhibitor: dose-optimization and patient phenotyping | 000 | 2 | NIH | 3/10/2026 | $612,382 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM129058 | Replication Of Chromosomes In Budding Yeast | 001 | 7 | NIH | 3/20/2026 | $45,762 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA227636 | Molecular Glues to Target RAS-MAPK Driven Cancers | 000 | 10 | NIH | 2/27/2026 | $479,518 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA292178 | Targeting Chromosomal Instability in the Evolution of Resistance to Matched Therapies Against Colorectal Cancer to Extend Treatment Response | 000 | 2 | NIH | 2/27/2026 | $246,840 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA280657 | Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer | 000 | 4 | NIH | 2/27/2026 | $727,224 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG080684 | Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | 001 | 4 | NIH | 2/24/2026 | $79,778 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA288692 | HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma | 000 | 3 | NIH | 3/3/2026 | $594,012 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AG087529 | Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease | 001 | 2 | NIH | 2/23/2026 | $87,110 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM152927 | In vivio single-cell analysis of dynamic cell behaviors | 001 | 3 | NIH | 2/24/2026 | $439,849 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD020111 | Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | 001 | 2 | NIH | 2/22/2026 | $74,849 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01AI196346 | Understanding and manipulating microbiome ecology to curb gut-borne infections. | 000 | 1 | NIH | 2/20/2026 | $3,519,992 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | K00CA284294 | Engineering Biomaterials to Modulate the Tumor Immune Microenvironment | 000 | 4 | NIH | 1/20/2026 | $94,288 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R35GM136278 | DNA Damage & DNA Replication: a Complex Relationship | 000 | 6 | NIH | 2/20/2026 | $972,560 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01GM088253 | Template-based replication of the centriole organelle | 000 | 16 | NIH | 1/19/2026 | $351,370 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01CA290231 | Targeting isocitrate dehydrogenase mutations by enzyme hyperactivation | 000 | 3 | NIH | 1/14/2026 | $427,285 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R21CA296688 | Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization | 000 | 2 | NIH | 1/6/2026 | $185,131 |
| | 2026 | 2026 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 1275 YORK AVE | NEW YORK | NY | 10065-6007 | NEW YORK | USA | R01MD020111 | Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | 000 | 2 | NIH | 1/2/2026 | $673,652 |
|
